Tricida Investor Relations Material
Latest events
Q2 2022
Tricida
Access the full event backlog
Slides, Transcripts, and Reports from over 8,000 public companies
Tricida, Inc. operates as a pharmaceutical company. The Company is focused on the discovery and development of novel therapeutics for rare diseases. Tricida develops its product candidates through internal research efforts, which continue to generate the majority of data used in Tricida’s external partnering discussions with biopharmaceutical partners. The Company operates in the United States and internationally. Tricida, Inc was incorporated in 2013 and is headquartered in South San Francisco, California.
Latest articles
Webull vs Robinhood: Which Platform Suits You?
In the competitive world of online trading platforms, Webull and Robinhood have emerged as two of the top choices for investors.
24 Nov 2023
Norway's Sovereign Wealth Fund: Transforming Oil Wealth into Lasting Prosperity
But what makes Norway’s striking of oil so fundamentally different from its worse faring counterparts? The answer is in large part its Norwegian Government Pension fund, and Norges Bank Investment Management
24 Nov 2023
Danaher Business System and Acquisition History
Since the early 1990s, Danaher's management team has transformed a group of under-performing industrial manufacturing companies into a global powerhouse in life sciences and diagnostics.
22 Nov 2023
Ticker symbol
TCDA
Country
🇺🇸 United States